METSYSTEM

Targeting Metastasis,
Transforming Treatment

We personalize cancer care
Through advanced drug screens and metastatic insights, we identify the most effective treatment for each patient’s journey.

WHAT WE DO
Advancing Precision Treatment for Cancer Patients.

Each patient is different and so is their cancer.

Metsystem’s innovative platform, METscreen, is transforming cancer care by addressing the complexities of metastasis. Using metastasis-targeting technologies and patient-derived organoids, our mission is to predict if and where cancer will spread and identify the most effective treatment for each patient. METscreen is an advanced, functional assay that accounts for intratumor heterogeneity, providing doctors with actionable insights tailored to each unique case.

read the news

Follow our work...

read more on LinkedIn

METscreen, is transforming cancer care by addressing the complexities of metastasis. Using metastasis-targeting technologies and patient-derived organoids, our mission is to predict if and where cancer will spread and identify the most effective treatment for each patient. METscreen is an advanced, functional assay that accounts for intratumor heterogeneity, providing doctors with actionable insights tailored to each unique case.

By bridging cutting-edge science with clinical application, METscreen, empowers doctors to make precise, informed treatment decisions based on the cancer’s actual response. With broad potential across multiple cancers and therapeutic use cases, our platform is setting a new standard for personalized care in metastatic cancer treatment.